OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

REGENERON PHARMAC.DL-,001/  US75886F1075  /

Lang & Schwarz
3/16/2025  6:02:52 PM Chg. 0.00 Volume Bid6:02:52 PM Ask6:02:52 PM Market Capitalization Dividend Y. P/E Ratio
610.00EUR 0.00% -
Turnover: -		 610.00Bid Size: - 611.40Ask Size: - 67 bill.EUR - -
 

Master data

WKN: 881535
Ticker: RGO
Currency: EUR
Type: Stock
Issue type: Common stock
Trading segment: -
Next exchange holiday: 4/18/2025
Indices: Nasdaq 100, baha us 500, baha us tech 100

Quote data

Open: 610.00
High: 610.00
Low: 610.00
Previous Close: 610.00
Volume (shares): -
Turnover: -
Trades: 620
Market phase: -
 
  All quotes in EUR

Performance

1 Week
  -11.23%
1 Month
  -5.43%
3 Months
  -13.43%
YTD
  -9.23%
1 Year
  -30.84%
3 Years
  -0.85%
5 Years  
+35.65%
10 Years  
+38.16%
1W High / 1W Low: 687.20 609.20
1M High / 1M Low: 687.40 609.20
6M High / 6M Low: 1,028.00 609.20
High (YTD): 1/9/2025 712.40
Low (YTD): 3/14/2025 609.20
52W High: 8/19/2024 1,075.50
52W Low: 3/14/2025 609.20
Avg. price 1W:   633.14
Avg. volume 1W:   0.00
Avg. price 1M:   653.68
Avg. volume 1M:   0.00
Avg. price 6M:   748.33
Avg. volume 6M:   0.00
Avg. price 1Y:   849.34
Avg. volume 1Y:   0.00
Volatility 1M:   39.98%
Volatility 6M:   34.01%
Volatility 1Y:   28.55%
Volatility 3Y:   32.35%
Dividend per Share: - 
Earnings per Share: 40.90 USD
Return on Equity: 15.03%
Dividend Yield:   -
P/E Ratio:   16.30
Market Capitalization:   67 bill. EUR
Free Float Market Cap.:   - 

Sector comparison

  Amgen Inc.Vertex Pharma...Regeneron Pha...Gilead Scienc...Nasdaq 100
Overview  
ISIN  US0311621009US92532F1003US75886F1075US3755581036US6311011026
Market Capitalization
154.88 bill. EUR119.13 bill. EUR67 bill. EUR127.55 bill. EUR-
Shares Outstanding
537.2 mill.256.79 mill.107.51 mill.1.25 bill.-
Dividend per Share*
9.13 USD- - 3.08 USD-
Dividend Yield
2.91%--2.76%-
P/E Ratio
41.17-16.30293.26-
P/E Ratio (with EPS Diluted)*
34.48-193.6118.58243.08-
Free Float
76.20%82.70%68.40%99.89%-
Performance  
Exchange  NASDAQNASDAQNASDAQNASDAQIndices Nasdaq
1 Week
-4.17%+0.95%-10.47%-4.92%+1.41%
1 Month
+7.74%+9.97%-1.00%+7.07%-10.90%
3 Months
+17.96%+7.57%-9.88%+20.09%-10.44%
YTD
+20.36%+25.35%-6.38%+20.65%-6.22%
1 Year
+16.68%+23.81%-30.86%+51.23%+10.65%
3 Years
+33.01%+101.91%-2.68%+88.24%+39.57%
5 Years
+50.97%+139.86%+35.63%+49.54%+163.64%
Fundamentals  2024202420242024-
Accounting Standard  US GAAPUS GAAPUS GAAPUS GAAP-
Revenues (in mill.)
33,424 USD11,020.1000 USD14,202 USD28,754 USD-
Revenues Growth Rate
18.57%11.66%8.27%6.04%-
EBITDA (in mill.)
- - - - -
Operating Result (in mill.)
7,258 USD-232.9000 USD3,990.7000 USD1,662 USD-
Income Before Taxes (in mill.)
4,609 USD248.5000 USD4,779.9000 USD690 USD-
Net Income (in mill.)
4,090 USD-535.6000 USD4,412.6000 USD480 USD-
Net Income Growth Rate
-39.11%-114.80%11.61%-91.53%-
Earnings per Share
7.62 USD-2.08 USD40.90 USD0.38 USD- USD
Total Equity (in mill.)
5,877 USD16,409.6000 USD29,353.6000 USD19,246 USD-
Equity Ratio
6.40%72.82%77.74%32.62%-
Return on Equity
69.59%-3.26%15.03%2.49%-
Book Value per Share
10.94 USD63.90 USD273.04 USD15.45 USD-
Total Assets (in mill.)
91,839 USD22,533.2000 USD37,759.4000 USD58,995 USD-
Return on Assets
4.45%-2.38%11.69%0.81%-
Operating Cash Flow (in mill.)
11,490 USD-492.6000 USD4,420.5000 USD10,828 USD-

 * Latest financial year